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C-reactive protein (CRP) is a potential biomarker whose elevated levels in humans determine cardio-
vascular disease risk and inflammation. In this study, we have developed a novel capacitive biosensor
for detection of CRP-antigen using capacitor with interdigitated gold (GID) electrodes on nanocrys-
talline diamond (NCD) surface. The NCD surface served as a dielectric layer between the gold electrodes.
GID-surface was functionalized by antibodies and the immobilization was confirmed by Fourier trans-
form spectroscopy (FT-IR) and contact angle measurements. The CRP-antigen detection was performed
by capacitive/dielectric-constant measurements. The relaxation time and polarizability constants were
estimated using Cole–Cole model. Our results showed that the relaxation time constant () of only CRP-
−16 −13 −11
-reactive protein
iosensor
antibodywaswithin 10 –10 s,whichwas increased to 10 s after the incubationwith CRP-antigen,
suggesting that the CRP-antigenwas capturedby the antibodies onGID-surface. In addition, polarizability
constant (m) ofCRPwasalso increasedupon incubationwith increasingconcentrationofCRP-antigen.Our
results showed that the response of GID-NCD-based capacitive biosensor for CRP-antigenwas dependent
on both concentration (25–800ng/ml) aswell as frequency (50–350MHz). Furthermore, using optimized
conditions, the GID-NCD based capacitive biosensor developed in this study can potentially be used for
ls ofdetection of elevated leve
. Introduction
C-reactive protein (CRP) is one of the plasma proteins known
s acute-phase proteins and its level rise dramatically during
nflammatory processes occurring in the body. This increment is
ue to a rise in the plasma concentration of IL-6, which is pro-
uced predominantly bymacrophages aswell as adipocytes (Pepys
nd Hirschfield, 2003; Lau et al., 2005). CRP can rise as high as
000-folds with inflammation. Conditions that commonly lead to
arked changes in CRP include infection, trauma, surgery, inflam-
atory conditions, advanced cancer and moderate changes occur
fter strenuous exercise, heatstroke, and childbirth (Pepys and
irschfield, 2003; Casas et al., 2008). CRP was found to be the only
arker of inflammation that independently predicts the risk of a
eart attack (Pepys and Hirschfield, 2003; Hansson, 2005; Casas
t al., 2008). The risks for cardiovascular diseases defined by the
merican Heart Association (AHA) and the Center for Disease Con-
rol and Prevention (CDC) are low for a CRP concentration below
.0mg/l, moderate for a CRP level from 1.0 to 3.0mg/l, and high for
oncentrations over 3.0mg/l (Yang et al., 2009).
∗ Corresponding author. Tel.: +90 216 483 9533; fax: +90 216 483 9550.
E-mail address: yasar@sabanciuniv.edu (Y. Gurbuz).protein risk markers in suspected subjects for early diagnosis of disease.
In order to measure a lower CRP concentration in clinical lab-
oratories, an ELISA protocol is commonly used with a detection
limit as low as 1.0mg/l (Ledue and Rifai, 2001). An immunosen-
sor was designed using potential and ac impedance methods to
obtaineda lineardetection rangeof5–25mg/lCRP (Zhuet al., 2003).
Recently, there are several advancements for measuring CRP has
been reported. Forexample, aCRPassaybyusingamagneticperme-
ability detector has been reportedwith a detection limit of 0.2mg/l
(Kriz et al., 2005). A label-free assay using surface plasmon reso-
nance (SPR)-based technology was demonstrated with a detection
limit of 2–5mg/l (Meyer et al., 2006). Furthermore, a novel mag-
netic biosensor for CRP antibodies was developed and showed a
linear detection range from 25g/l to 2.5mg/l (Meyer et al., 2007).
In an another approach, magnetic nanoparticles conjugated with
labeled anti-CRP-antibody were used to perform an immunoas-
say that is shown to have a detection limit of 0.12mg/l (Tsai et
al., 2007). The detection limit was improved to 0.005mg/l using
an RNA-based aptasensor by optical based SPR method (Bini et al.,
2008). An integrated microfluidic system was developed using the
microfluidic chip incorporated with magnetic beads coated with
specific DNA aptamers and the detection limit was improved from
0.125 to 0.0125mg/l (Yang et al., 2009). However, in order to obtain
this lower limit of detection, the acridinium-labeled antibodies
were used for sandwich type chemiluminescence measurements.
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Pevertheless, all these methods that still require labor-intensive
rocessing and large and expensive equipments for measurement
f the CRP that requires expertise.
Capacitancemeasurement could be a useful tool for immunoas-
ays (Christine et al., 2001). The attraction of affinity-based
apacitive sensors is that they are able to determine the analyte
irectly in a sample with no or very little sample preparation.
he measuring principle of these sensors is based on changes in
ielectric properties, charge distribution, and conductivity change
hen an antibody–antigen complex formed on the surface of
n electrode. Capacitive affinity biosensors can be constructed
y immobilizing recognition elements, such as antibodies in thin
ayers on the electrodes, and measuring changes in the dielec-
ric/surface properties when an analyte binds. For providing
arger sensor surface, conductors can be made into a pattern of
nterdigitated fingers. The capacitance between the interdigitated
lectrodes can then be described by the basic capacitance equa-
ion C=2nεε0A/d, where ε is the dielectric constant of the medium
etween the plates, ε0 is the permittivity of free space, A is the area
f the electrodes and d is the distance between the two electrodes,
being the number of electrodes (12 in this study) and finally the
actor 2 in this equation represent to each electrode forming two
apacitors. Thus, when there is a change in the dielectric proper-
ies of thematerial between the plates, a change in the capacitance
ill occur and it is correlated to the bound antigen molecules
aptured by antibodies on the surface, as well as between the
lectrodes.
In a complex protein, positive and negative charges are consti-
uted from the ionizable side chains of acidic and basic amino acid
resent in theprotein structure. The simplestmolecular dipole con-
ists of a pair of opposite electrical charges with magnitude of +q
nd −q and separated by r, vector distance. The molecular dipole
oment m is given by the equation m=qr. Each type of polar or
olarizable entitywill exhibit its own characteristic response to the
mposedelectricfield.Whenaprotein is immobilizedona solid sur-
ace and allowed to bind its analyte, a protein–analyte complex is
ormed. The change in conformation brought on by this interaction
eads to an increase inmolecular size of a protein–analyte complex.
his increase in size of a protein–analyte complex therefore leads
o a relatively large permanent dipolemoment. The relaxation time
nd polarizability constants can thus be estimated (Cole and Cole,
941).
In this paper, to our knowledge, for the first time, a new capac-
tive immunosensor was developed, based on gold interdigitated
lectrodes fabricated onGID-NCD surface to detect CRP. Using CRP-
ntibody as the model ligand/substrate, a direct detection of CRP
y capacitance/dielectric measurements was demonstrated using
heterostructure of GID-NCD surface covalently bound with CRP
ntibodies on GID region. When the immobilized CRP-antibody
nteracts with CRP-antigen, the interaction leads to the change in
hickness of the dielectric layer on GID-NCD surface, and induces
hange in capacitance which can directly be related to detect the
ntigen.
. Materials and methods
.1. Reagents and materials
Monoclonal antibodies and purified antigen, C-reactive
rotein was purchased from Fitzgerald Industries Interna-
ional (Concord, MA, USA). 3-Mercaptopropionic acid, N-(3
imethylaminopropyl)-N-ethylcarbodiimide hydrochloride (EDC),
nd N-hydroxysuccinimide (N-hydroxy-2,5-pyrrolidinedione,
HS) were obtained from Sigma–Aldrich (Steinheim, Germany).
BS and Tween 20 were purchased from Sigma (USA). All otherreagents and solvents were of analytical grade and the doubly
distilled water was used throughout the experiments.
2.2. Synthesis of NCD film and characterization
NCD films were formed with the process of the CH4/H2/N2
gases in a Microwave Plasma Enhanced Chemical Vapor Depo-
sition (PECVD), employing growth rate reduction conditions and
using anASTeX® reactor equippedwith a 2.45GHzmicrowave gen-
erator. The pre-treatment process of the silicon (100) substrate
consisted of mechanical polishing of the surface using diamond
powder (2.5m size) followed by ultra-sonication with diamond
powder of 5–20nm size in acetone solution to augment diamond
nucleation. A gaseous mixture of CH4/H2/N2 with flow rates of
15/8/190 sccm, respectively, was introduced into the CVD system
at a pressure of 20Torr with the substrate temperature being
800 ◦C, and microwave power at 550W. The growth rate of the
diamond deposition process was controlled to be 0.1m/h, in
order to achieve nm-scaled grains of diamond. Scanning electron
(JSM-5600LV-SEM) and optical micrographs of the nanocrystalline
diamond surfaces were carried for characterization. These NCD
films were used for GID array patterning for fabrication of capaci-
tors.
2.3. Fabrication of GID array electrodes on NCD surface for
fabrication of capacitors
The GID array capacitors (GID-NCD chips) were fabricated by
following steps. First, the GID array electrodes were patterned on
NCD film surface using image reversal technique. In this process
the metal layers were patterned using the dual tone photoresist
AZ 5214 E. Very thin tungsten layer of 50nm size was DC sputter
deposited on the NCD film, which was used to improve the adhe-
sion of gold on substrate. Next, gold particles of 500nm size were
deposited using DC sputtering. Following this step, the gold layer
was patterned by image reversal techniquewith the help of amask.
Length of each electrode was 750m and a width of 25m and
a distance between two electrodes was 25m. A 40m deep SU8
wellswere patterned over theGID structure for easing the antibody
immobilization on the sensor structure. As a result, each GID array
on a capacitor contained 24 GID fingers. A series of such capacitors
were fabricated for detection of CRP-antigens. The surface char-
acterization was performed using a nanoscope AFM (Nanoscope)
with the tapping mode and by optical micrographs.
2.4. Immobilization of CRP antibodies on GID electrodes
The immobilization of CRP-antibodies on GID electrode surface
of capacitors was carried out in a two step reaction. First, the chips
were immersed in a 10mM solution of mercaptopropionic acid
(MPA) at room temperature for 24h and a self-assembled mono-
layer (SAM) was formed (Riepl et al., 1999). The SAM layer of MPA
on GID electrodes was thoroughly rinsed with distilled water and
driedoverpurenitrogengas. The formationof SAMisa spontaneous
reaction by adsorption of MPA on gold surface by sulfide linkage as
shown in the following chemical reaction (Warakorn et al., 2006).
RSH + Au → RS−Au+·Au + 1/2H2 (1)
or disulfide
RS–SR + Au → RS−Au+·Au (2)
The affinity between sulfur and gold atoms is shown to be
extremely high, and the resulting SAMs are highly stable in air,
water, and organic solvents at room temperature (Warakorn et
al., 2006; Chaki and Vijayamohanan, 2002; Wadu-Mesthrige et al.,
2000). In the second reaction, the CRP antibodieswere immobilized
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pn SAMs through covalent binding. For this, the carboxylic groups
fMPA (SAM) onGID electrodeswere activated by adding 0.05Mof
DC and 0.03MofNHS inwater for 5h. The activatedGID-electrode
as then incubated with 20l of 100g/ml CRP antibodies in PBS
as amodel sample) for 1h at room temperature. TheGID-electrode
urface immobilized with CRP antibodies was washed thrice with
BS buffer followed by double distilled water. The free/unoccupied
arboxyl groups on GID electrodes was blocked by adding 100mM
thanolamine inPBSbuffer and incubated for 2hat 4 ◦Candwashed
gainwith PBS buffer. Finally, the immobilization of antibodieswas
onfirmed by IR spectrum using a THERMO (Nicolet) 6700 Model
T-IR spectrometer and contact angle measurements.
.5. Detection of CRP-antigen and characterizations
A series of capacitors were used for detection of different con-
entrations of CRP-antigen (at least two capacitors for the detection
f each concentration of CRP). Detection process was performed
y incubating CRP-antigen on GID electrode region of a capaci-
or. Initially, a series of CRP-antigen concentrations (0–1000ng/ml)
ere prepared in PBS buffer. The capacitors were then incu-
ig. 1. Scanning electron micrographs of (a) the NCD film on silicon substrate and (b) cros
ortion of sensor surface (dimension of the electrode was 750m×25m) with spacingbated for 1h with different CRP-antigen concentrations in 2l
volume each. The dielectric parameters (impedance/capacitance)
were measured before and after the antigen treatment. First, the
dielectric parameters were measured with (a) blank capacitor, (b)
capacitor after SAM formation, (c) after surface activation, (d) after
CRP-antibody immobilization, and compared the results with (e)
after capturing of different concentrations (25, 100, 500, 800 and
1000ng/ml) of CRP-antigen by antibodies on capacitors. The dielec-
tric parameters (impedance/capacitance) were measured in the
frequency range 50MHz–1GHz usingNetwork Analyzer (Karl-Suss
PM-5 RF Probe Station and Agilent-8720ES). Network analyzer was
calibrated using SOLT (short-open-load-through) method. Dielec-
tric constant and conductivitywere calculated frommeasurements
of the sample capacitance and resistance. A negative control exper-
iment was also conducted under standard conditions using bovine
serum albumin (BSA) as a non-specific protein in place of CRP-
antigen.
Dielectric constant and conductivity valueswere extracted from
the data measurements at frequency (f) of 50–425MHz range
for plotting. Further, the relaxation time and polarizability con-
stantswere estimatedusingCole–Colemodel (Cole andCole, 1941).
s-sectional image; optical micrographs of (c) GID-NCD surface and (d) a magnified
between two electrodes was 25m; and (e) AFM image of the sensor surface.
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dielectric properties using Network analyzer (Karl-Suss PM-5 RF
Probe Station and Agilent-8720ES). The variation in the values of
the dielectric constants as a function of frequency was plotted
(Fig. 3). Further analysis was performed by plotting the values of
dielectric constants against different concentrationsofCRP-antigen
Fig. 3. The change in dielectric constant values of CRP-antigen–antibody com-Fig. 2. FT-IR spectrum of the gold-interdigitated on nanocrystalline diamond su
verage values of dielectric properties obtained from at least two
apacitors for each antigen concentrationwas plotted and the stan-
ard deviations are shown as errors.
. Results and discussion
In this studywereport on thedevelopmentof anovel capacitive-
ased biosensor for detection of CRP-antigen. Here, the antibodies
pecific for CRP-antigen were used as bio-recognition elements in
his capacitive-based biosensor. For this, initially GID-array capaci-
ors were fabricated on NCD films. The NCD surface allowed a good
ielectric layer between the GID electrodes. The antibodies were
mmobilized on GID-surface of the capacitors. The CRP-antibody
unctionalized capacitors were incubated with a series of CRP-
ntigen concentrations. As a result, the signal generated due to the
ormation of antibody–antigen complex on capacitor surface was
etermined by measuring the dielectric properties.
.1. Characterization of GID-NCD surface
The NCD films were prepared on silicon substrates by CVD
echnique onto which the GID arrays to be patterned. The sur-
ace characteristics was observed by SEM and the diamond surface
as found to be homogenous, flat and nonporous (Fig. 1a). Fur-
her, the surface texture showed a thickness of ∼1.5m NCD film
n silicon substrate (Fig. 1b). The GID electrode arrays were then
atterned as described in materials and methods. The distribution
f gold nanoparticles on NCD film was found to be homogenously
ell distributed as shown inopticalmicrographs andanAFM image
Fig. 1c–e). The thickness of sputtered gold was about 500nm on
he NCD film surface.
.2. Confirmation of antibody immobilization on GID arrays of
apacitors
FT-IR spectrum of the GID-NCD surface was recorded before
nd after the antibody immobilization. The FT-IR spectra of GID-
CD before immobilization showed only an absorption peak at
200–2400 cm−1 (2360 cm−1) wave number that represents the
tretchvibrationof Si–HgroupsofNCDonsilicon substrate (Fig. 2a).
he FT-IR spectra after the antibody immobilization showed the
resence of N–H bonding (1730 cm−1) on GID arrays, indicating
hat antibodies were successfully immobilized (Fig. 2b). The less
ntense peak at 1450 cm−1 shows the presence of normal amine.
he peak at 1160 cm−1 shows the C–N stretch.capacitor): (a) before (blank surface) and (b) after the antibody immobilization.
Further, contact angle was measured on self-assembled mono-
layer formed on the GID-NCD surface before and after the antibody
treatment. The hydrophilicity brought on by SAM formation fol-
lowed by antibody immobilization was confirmed by its contact
angle of 73◦ and 60◦, respectively. This result also showed that the
antibody immobilization on the surface increased the hydrophilic-
ity of the surface.
3.3. Detection of CRP-antigens using CRP-antibody functionalized
capacitors
A series of capacitors functionalized with CRP antibodies
were incubated with different concentrations of CRP-antigen
(0–1000ng/ml). The capturing of CRP-antigen was measured byplex on GID-NCD surface (capacitor) as a function of frequency (50–425MHz).
The CRP-antibodies immobilized GID-NCD-capacitors were incubated with differ-
ent concentrations of CRP-antigen (0–1000ng/ml) and dielectric properties were
measured. A negative control was performed with BSA protein (800ng/ml) that
showed no response. The inset figure shows variation in the conductivity values of
antigen–antibody complex on capacitor surface as a function of frequency.
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Cig. 4. The change in dielectric constant values of CRP-antibody–antigen complex o
requencies as shown in the figure legend and (b) at a specific frequency of 208MH
Fig. 4a andb). Itwasobserved fromtheabovefigures that dielectric
onstant passed through dielectric dispersion and decreased with
requency (Grant, 1983). The conductivity was increased with the
ncreasing CRP-antigen concentration at a constant frequency (see
nset of Fig. 3). The data points of the dielectric change for linear fit
t one of the frequencies was plotted against the concentrations of
ntigen and the coefficient of variation (CV)was found to bewithin
4%. Fig. 4b showed the concentration versus dielectric change at
frequency of 208MHz was linear over 25–1000ng/ml antigen
oncentration range (R2 = 0.9255 with CV(%) of 1.72) (Fig. 4b).
Protein molecules, such as CRP-antigen and CRP-antibodies are
omposed of one or more polypeptide chains folded in a complex
nd fractural geometry. Polypeptide bonds, amino acid side chains
nd solvent molecules are organized at different levels to control
econdary and three-dimensional structure of proteins through
he formation of peptide bonds as shown in the reaction (see
upplementary information Fig. S1).
The N–C bond in the peptide units has a partial double bond
haracter, so that the six atoms C NHCO C are coplanar. In addi-
ion, the C Obond is itself polar, so that the peptide bondpossesses
permanent dipole moment. Since each peptide unit possesses
permanent dipole moment, polypeptide chains take the form
f strings of connected dipoles. The drop in values of dielectric
onstant with frequency was possibly because of the rotational
elaxation of the protein molecules ( dispersion) (Pethig and Kell,
987). In this study, the relaxation time for CRP-antibody alone
as in the range 10−16–10−13 s. This relaxation time was found to
e elevated to 10−11 s when a series of CRP-antigen concentration
as exposed. It was found that the larger molecule of a protein
as a greater relaxation time (Pethig and Kell, 1987; Song, 2002;
obrikova et al., 2007). Our results suggest that the CRP-antigen
as captured by CRP-antibodies present on the surface of the het-
rogeneous sensor structure. As a result, the CRP-antigen–antibody
omplex becomes larger inmolecular size than antibody alone, and
herefore, the increase in relaxation time was correlated to the
ncrease in the size of a protein molecule. The impedance equiv-
able 1
alues of dielectric dispersion and polarizability constants for blank (no antigen but con
RP-antigen.
Parameter CRP-antigen concentration (ng/ml)
0 25
aDielectric dispersion (ε′) 5951.43 5186.56
Polarizability constant (m) 0.5093 0.5305
a The dielectric despertion values presented in the table are for 24 fringes on each capacitor surface as a function of different concentrations of CRP-antigen at (a) different
alent network circuit based on Cole–Cole model (Cole and Cole,
1941) of GID-NCD sensor is given by the following equations:
Z(ω) = Z(o)
{
1 − m
[
1 − 1
1 + (jω)c
]}
(3)
Ro = Z(o) (4)
R∞ = Z(o)[1 − m] (5)
where R∞ is the high frequency impedance, Ro is the low frequency
impedance, m is the polarizability constant, and  is the relax-
ation time constant. Further, the ploarizability constant (m) was
calculated before and after the formation of CRP-antibody–antigen
complex by fitting the values of impedance using the Eqs. (3)–(5).
The polarizability constant value of only antibody on the sensor
surface was calculated to be 0.5093, and this value was increased
to 0.766 after incubation with CRP-antigen (Table 1).
The increase in thevalueof polarizability constant canbe related
to the rotational motion of the protein molecule upon binding of
antibodies to CRP-antigen (Pethig and Kell, 1987; Schwan, 1968). It
was also observed that the dielectric dispersion ε′ = (ε′s − ε′∞) for
control was lower than the antigen treated sample. The changes in
the value of ε′ were attributed to change in shape and volume
of protein molecules (Hasted, 1973). It is clear from our results
that the values of conductivity increased, which accompanied by
a decrease in the values of dielectric constant (see Fig. 3). Our
results showed that the response of this capacitive-based sen-
sor for CRP-antigen protein was dependent on concentration in
a range 25–800ng/ml of CRP-antigen as well as frequency at a
range 50–350MHz (Fig. 3). However, at a particular frequency (for
e.g., 208MHz), the linearity was extended from 800 to 1000ng/ml
(Fig. 4b), but at higher frequency (for e.g., 400MHz), the maximum
limit was only up to 800ng/ml. The concentration and frequency
above 800ng/ml and 350MHz, respectively showed no increase in
response by this sensor system (Figs. 3 and 4a). This was possibly
because of saturation of antibody binding sites on the sensor sur-
face. In addition, the sensor surface was bio-functionalized with a
tains only antibodies on sensor surface) and tests with different concentration of
100 500 800 1000
5000.31 5120.99 5448.04 5096.36
0.5799 0.6016 0.7143 0.766
citor.
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constant amount of CRP-antibody (100g/ml). It is clear that there
re limited binding sites on CRP-antibodies and thus the limita-
ion of CRP-antigen binding capacity. Further, a negative control
xperiment was performed by using BSA protein (800ng/ml) to
scertain that no non-specific signal occurred on a capacitor chip
oated with CRP-antibodies. The results showed that BSA did not
ind to antibodies on the chip surface (Fig. 3).
Several detection methods have been employed for sensi-
ive detection of CRP-antigen. For example, the detection of CRP
eported by electrochemical method shown to be in a range
–25mg/l (Zhu et al., 2003), magnetic permeability immunoassays
ith a lower detection limit of 0.2mg/l (Kriz et al., 2005), by SPR in
range 2–5mg/l (Meyer et al., 2006), andmagnetic biosensor with
broad range of 25g/l–2.5mg/l (Meyer et al., 2007). The most
ensitive techniques of all the above was by ELISA with a lowest
etection limit of 1mg/l (Ledue and Rifai, 2001) and by using spe-
ific DNA aptamers through labeled CRP-antibodies andmeasuring
hemiluminescence was 0.125–0.0012mg/l (Yang et al., 2009).
owever, the methods reported in the literature are often expen-
ive that are either sandwich type (more prone to cross-reactivity)
r at least required a fluorophore for sensitive detection. There-
ore, we here report for the first time, by use of a capacitor based
iosensor, it was possible to detect CRP in a range 0.025–0.8mg/l.
he advantage of the proposed capacitor based detection of CRP
ver other methods is being its label-free nature, ease of use, less
xpensive, required minimum sample preparation, and direct sig-
al readout in the form of electrical signal. All these cannot be
ffered by different approaches, such as SPR or sandwich type
uorescence detection. Above all, the optical sensors (SPR), chemi-
uminescence, or ELISA require lab based equipment or chemical
uorophores to read the signal (Bini et al., 2008; Yang et al., 2009).
urther, under optimized assay conditions, the capacitive biosen-
or can be applied to detect other disease markers for testing with
eal serum samples. It should be noted that the dielectric layer
NCD) between the gold electrodes and their geometry contributes
o improve the analytical performance. The use of NCD as a dielec-
ricmaterial prevents physical adsorption of constituents, masking
nd interference in dielectric signal. Furthermore, the optimization
f the geometry of GID electrode and dielectricmaterial for the fab-
ication of a capacitor chip would allow enhancing the sensitivity
f capacitive biosensor.
. Conclusion
In summary, we have developed a novel capacitive biosensor
or detection of CRP-antigen, using interdigitated gold elec-
rodes/nanocrystalline diamond capacitive structure, immobilized
ith human CRP-antibodies. The response and sensitivity of this
apacitive-basedbiosensor for CRP-antigenwasdependent onboth
oncentration and applied frequency. The values of relaxation time
) and polarizability constants (m) of CRP were increased upon
ncubation with increasing concentration of antigen suggesting
hat the CRP-antigen was captured by the antibodies on the sensor
latform. The dynamic detection range using optimized conditions
or a given antibody concentration (100g/ml) was found to be in
he range 25–800ng/ml of CRP-antigen. This range falls within the
oncentration levels of CRP-antigen in a cardiovascular disease risk
onditions. The sensitivity can be greatly improved by manipulat-
ng the surface area of capacitive sensor as well as the antibody
oncentration for immobilization. However, there are limitationswith respect to the application of capacitive-based biosensors as a
tool to specifically identify macromolecules in real serum samples.
In physiological solutions, ions, such as sodium and chloride, cre-
ate large conductive losses. Furthermore, the ions create a sheath
around the polar groups of the macromolecules that maymask the
desired signal and the macromolecule tends to blur the dielectric
relaxation spectrum over a large frequency.
Nevertheless, the capacitive biosensor developed in this study is
an inexpensive tool because it does not require expensive fluores-
cent dyes, reagents, and sophisticated instruments. It is a versatile
technique that can be potentially applied for detection of elevated
CRP levels in suspected subjects for early diagnosis of cardiovas-
cular disease. Finally using optimized conditions, the capacitive
biosensor can also be applied for detection of various other dis-
eases using novel biomarkers or probes for diagnosis or detection
of environmental contaminants.
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